Why Roche Oncology Bet Big On Neoantigen-Directed T-Cell Therapy

 
• By Emily Hayes
  
Ship wheel, exploring new frontiers. Digital illustration. - Illustration
Roche wants to chart new directions in T-cell receptor therapies
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Cell Therapies

More from Advanced Therapies